Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans
- 25 April 2011
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 108 (22), 9262-9267
- https://doi.org/10.1073/pnas.1104836108
Abstract
Antiinflammatory drugs achieve their therapeutic actions at least in part by regulation of cytokine formation. A "cytokine hypothesis" of depression is supported by the observation that depressed individuals have elevated plasma levels of certain cytokines compared with healthy controls. Here we investigated a possible interaction between antidepressant agents and antiinflammatory agents on antidepressant-induced behaviors and on p11, a biochemical marker of depressive-like states and antidepressant responses. We found that widely used antiinflammatory drugs antagonize both biochemical and behavioral responses to selective serotonin reuptake inhibitors (SSRIs). In contrast to the levels detected in serum, we found that frontal cortical levels of certain cytokines (e.g., TNFα and IFNγ) were increased by serotonergic antidepressants and that these effects were inhibited by antiinflammatory agents. The antagonistic effect of antiinflammatory agents on antidepressant-induced behaviors was confirmed by analysis of a dataset from a large-scale real-world human study, "sequenced treatment alternatives to relieve depression" (STAR*D), underscoring the clinical significance of our findings. Our data indicate that clinicians should carefully balance the therapeutic benefits of antiinflammatory agents versus the potentially negative consequences of antagonizing the therapeutic efficacy of antidepressant agents in patients suffering from depression.Keywords
This publication has 31 references indexed in Scilit:
- Reversal of Depressed Behaviors in Mice by p11 Gene Therapy in the Nucleus AccumbensScience Translational Medicine, 2010
- A Role for p11 in the Antidepressant Action of Brain-Derived Neurotrophic FactorBiological Psychiatry, 2010
- Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) reportPsychological Medicine, 2009
- Interferon-γ and Tumor Necrosis Factor-α Mediate the Upregulation of Indoleamine 2,3-Dioxygenase and the Induction of Depressive-Like Behavior in Mice in Response to Bacillus Calmette-GuérinJournal of Neuroscience, 2009
- A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorderInternational Journal of Neuropsychopharmacology, 2009
- Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major DepressionBiological Psychiatry, 2009
- IFN‐γ enhances neurogenesis in wild‐type mice and in a mouse model of Alzheimer's diseaseThe FASEB Journal, 2008
- Up-regulation of BDNF in Astrocytes by TNF-α: A Case for the Neuroprotective Role of CytokineJournal of Neuroimmune Pharmacology, 2006
- Interferon-γ Induces p11 Gene and Protein Expression in Human Epithelial Cells through Interferon-γ-activated Sequences in the p11PromoterPublished by Elsevier BV ,2003
- Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex AssayClinical and Vaccine Immunology, 2003